We're looking for the fiercest women in life sciences

Submit your nominations by Monday, Aug. 13 for consideration in this year’s list. (Gerd Altmann)

At first glance, it looks like we're getting somewhere. It is the era of #MeToo, of women speaking up about workplace harassment and discrimination, and of programs aimed at improving diversity in the life sciences industry. But despite progress, transparency and awareness, old challenges remain.

Two years after LifeSci Advisors' infamous model-staffed J.P. Morgan afterparty prompted widespread outrage, another industry-associated event objectified women—and triggered some anger. It was this year's Party At BIO Not Associated with BIO, or PABNAB. And at the 2018 J.P. Morgan conference, more men named Michael gave company presentations than female CEOs all together.

In spite of these and other obstacles, women continue to rise to the top of the life sciences field by starting their own companies, taking high-level positions, and otherwise making waves and shaping the industry. And they're paving the way for those who come after them.


Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

“We have gone from one woman on the leadership team to three or five: getting closer to equal numbers,” said Samantha Budd Haeberlein, head of clinical discovery and development for Alzheimer’s disease at Biogen, one of our 2017 honorees. “The conversation is today louder, more open and acceptable; not just the last bullet on a HR agenda topic.”

Each year at Fierce, we spotlight these trailblazing women. From industry professionals and academics to venture capitalists and regulatory officials, women are making their mark all over life sciences.

We invite you to share your nominations using the form below. We’re looking for women in biotech, pharma and medtech who stand out as leaders, innovators and mentors in organizations big and small. Be sure to submit your nominations by Monday, Aug. 13 for consideration in this year’s list, which will be published at the end of October. To get an idea of what we’re looking for, find last year's list here and 2016’s here.



Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.